Cite
Long follow-up of BNT162b2 mRNA vaccine in healthcare workers (2020-2022): A retrospective longitudinal SARS-CoV-2 serological surveillance.
MLA
De Pace, Vanessa, et al. “Long Follow-up of BNT162b2 MRNA Vaccine in Healthcare Workers (2020-2022): A Retrospective Longitudinal SARS-CoV-2 Serological Surveillance.” Human Vaccines & Immunotherapeutics, vol. 19, no. 2, Aug. 2023, p. 2258632. EBSCOhost, https://doi.org/10.1080/21645515.2023.2258632.
APA
De Pace, V., Bruzzone, B., Ricucci, V., Calcavecchia, N., Guarona, G., Giberti, I., Costa, E., Ogliastro, M., Galano, B., Nigro, N., Murgia, D., Nanni, L., & Orsi, A. (2023). Long follow-up of BNT162b2 mRNA vaccine in healthcare workers (2020-2022): A retrospective longitudinal SARS-CoV-2 serological surveillance. Human Vaccines & Immunotherapeutics, 19(2), 2258632. https://doi.org/10.1080/21645515.2023.2258632
Chicago
De Pace, Vanessa, Bianca Bruzzone, Valentina Ricucci, Nicola Calcavecchia, Giulia Guarona, Irene Giberti, Elisabetta Costa, et al. 2023. “Long Follow-up of BNT162b2 MRNA Vaccine in Healthcare Workers (2020-2022): A Retrospective Longitudinal SARS-CoV-2 Serological Surveillance.” Human Vaccines & Immunotherapeutics 19 (2): 2258632. doi:10.1080/21645515.2023.2258632.